Literature DB >> 23021716

The importance of the learning curve and surveillance of surgical performance in peritoneal surface malignancy programs.

Shigeki Kusamura1, Dario Baratti, Ionut Hutanu, Piero Rossi, Marcello Deraco.   

Abstract

Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) are complex procedures with a very steep a learning curve (LC). This study evaluates the LC of CRS and HIPEC in a single-center experience of peritoneal surface malignancies (PSMs). Approximately 140 to 150 cases were necessary for the acquisition of competence in CRS and HIPEC with adequate radicality and acceptable safety. Eighty to 100 cases were necessary to assure short-term prognostic gains in rare PSMs. This article highlights how LC and continuous monitoring of surgical performance is critical in evaluating the credibility of emerging and already established PSM centers.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23021716     DOI: 10.1016/j.soc.2012.07.011

Source DB:  PubMed          Journal:  Surg Oncol Clin N Am        ISSN: 1055-3207            Impact factor:   3.495


  6 in total

Review 1.  [Morbidity and mortality of hyperthermic intraperitoneal chemoperfusion].

Authors:  J O W Pelz; C-T Germer
Journal:  Chirurg       Date:  2013-11       Impact factor: 0.955

Review 2.  Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in gastrointestinal cancers: fad or standard of care?

Authors:  Melissa Ching Ching Teo; Grace Hwei Ching Tan
Journal:  Singapore Med J       Date:  2018-03       Impact factor: 1.858

Review 3.  Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a review of factors contributing to morbidity and mortality.

Authors:  Andrew D Newton; Edmund K Bartlett; Giorgos C Karakousis
Journal:  J Gastrointest Oncol       Date:  2016-02

4.  Preliminary Experience and Morbidity Analysis of Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC) from a Tertiary Cancer Center in India.

Authors:  Naveen Padmanabhan; Barath Raj Kumar; Ansar Pullampara Pookunju; Ayyapan Srinivasan; Vikash Mahajan
Journal:  J Clin Diagn Res       Date:  2015-06-01

5.  Outcome and factors associated with aborted cytoreduction for peritoneal carcinomatosis.

Authors:  Whitney Guerrero; Gitonga Munene; Paxton V Dickson; Zachary E Stiles; Johnathan Mays; Andrew M Davidoff; Evan S Glazer; David Shibata; Jeremiah L Deneve
Journal:  J Gastrointest Oncol       Date:  2018-08

6.  Cytoreductive surgery and intraperitoneal chemotherapy for peritoneal carcinomatosis of colorectal cancer: 2-year follow-up results at a single institution in Korea.

Authors:  Min Hyeong Jo; Jung Wook Suh; Jeong Seok Yun; Hwan Namgung; Dong-Guk Park
Journal:  Ann Surg Treat Res       Date:  2016-09-30       Impact factor: 1.859

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.